How does chorioretinal dystrophy affect vision over time, and what supportive measures or adaptations can help individuals manage vision impairment?

Chorioretinal dystrophy causes progressive damage to the retina and choroid, leading to impaired vision that can worsen over time. While there is no cure, supportive measures include regular ophthalmological monitoring, low-vision aids, adaptive technologies, and environmental modifications to enhance safety and independence.

What are the key signs of disease progression that patients or caregivers should monitor, especially concerning vision and movement?

Patients and caregivers should closely monitor for worsening balance and coordination (ataxia), an increase in falls, changes in walking style, and any further decline in vision or development of new abnormal eye movements like nystagmus. Regular neurological and ophthalmological assessments are crucial.

What treatment options are available to manage the hormonal imbalances, such as delayed puberty and short stature, associated with hypogonadotropic hypogonadism?

Hormone replacement therapy is the primary treatment for hypogonadotropic hypogonadism. This typically involves administering sex hormones (e.g., testosterone for males, estrogen/progesterone for females) to induce puberty and maintain secondary sexual characteristics. Growth hormone therapy may be considered for short stature.

What strategies or therapies are recommended to help manage the ataxia and maintain mobility as the condition progresses?

Physical therapy, occupational therapy, and balance training are essential to help manage ataxia, improve coordination, and maintain mobility. Assistive devices like walkers or canes may become necessary as the condition progresses to prevent falls and support independent movement.

Boucher-Neuhäuser syndrome

Boucher-Neuhäuser syndrome is a rare neurological disorder characterized by a combination of ataxia, hypogonadotropic hypogonadism, and chorioretinal dystrophy, with symptoms often worsening over time.

Overview

Boucher-Neuhäuser syndrome is a rare disorder that affects movement, vision, and sexual development. It is part of a continuous spectrum of neurological conditions, known as PNPLA6-related disorders, that share a genetic cause and have a combination of overlapping features. Boucher-Neuhäuser syndrome is characterized by three specific features: ataxia, hypogonadotropic hypogonadism, and chorioretinal dystrophy.

Ataxia describes difficulty with coordination and balance. In Boucher-Neuhäuser syndrome, it arises from a loss of cells (atrophy) in the part of the brain involved in coordinating movements (the cerebellum). Affected individuals have an unsteady walking style (gait) and frequent falls.

Another key feature of Boucher-Neuhäuser syndrome is hypogonadotropic hypogonadism, which is a condition affecting the production of hormones that direct sexual development. Affected individuals have a delay in development of the typical signs of puberty, such as the growth of facial hair and deepening of the voice in males, and the start of monthly periods (menstruation) and breast development in females. Other hormone abnormalities lead to short stature in some affected individuals.

The third characteristic feature of Boucher-Neuhäuser syndrome is abnormalities, most commonly chorioretinal dystrophy. Chorioretinal dystrophy refers to problems with the light-sensitive tissue that lines the back of the eye (the retina) and a nearby tissue layer called the choroid. These eye abnormalities lead to impaired vision. People with Boucher-Neuhäuser syndrome can also have abnormal eye movements, including involuntary side-to-side movements of the eyes (nystagmus).

The key features of Boucher-Neuhäuser syndrome can begin anytime from infancy to adulthood, although at least one feature usually occurs by adolescence. Ataxia is often the initial symptom of the disorder, but vision problems or delayed puberty can be the earliest finding. Vision and movement problems worsen slowly throughout life and can result in blindness or the need for a wheelchair for mobility in the most severely affected individuals.

People with Boucher-Neuhäuser syndrome can have additional medical problems, including muscle stiffness (spasticity); impaired speech (dysarthria); and difficulty processing, learning, or remembering information (cognitive impairment).

Frequency

Boucher-Neuhäuser syndrome is a rare condition. Its prevalence is unknown.

Causes

Most cases of Boucher-Neuhäuser syndrome are caused by mutations in the PNPLA6gene. Such mutations are the only known cause of the condition. Researchers speculate that as-yet-unidentified mutations in the PNPLA6 gene or changes in other genes are involved in the remainder of cases.

The PNPLA6 gene provides instructions for making a protein called neuropathy target esterase (NTE), which helps regulate the amount of certain fats (lipids) that make up the outer membrane surrounding cells. The correct levels of these lipids are critical to the stability and function of cell membranes. In particular, the NTE protein breaks down (metabolizes) a lipid called lysophosphatidylcholine, which in high amounts can damage cells. NTE is found most abundantly in the nervous system and is thought to help maintain the stability of membranes surrounding nerve cells. NTE is also thought to play a role in the release of hormones from the pituitary gland, a process that requires particular changes in the cell membrane. The pituitary gland is located at the base of the brain and produces several hormones, including those that help direct sexual development and growth.

PNPLA6 gene mutations are thought to impair NTE's function. However, it is unclear how these mutations cause Boucher-Neuhäuser syndrome. Researchers speculate that impairment of lysophosphatidylcholine metabolism alters the balance of lipids in the cell membrane. This imbalance may damage neurons, leading to the movement and vision problems that characterize Boucher-Neuhäuser syndrome. The imbalance may also impair the release of hormones involved in sexual development, accounting for the delayed puberty in affected individuals.

Researchers are unsure how mutations in the PNPLA6 gene lead to different combinations of features, resulting in the spectrum of PNPLA6-related disorders.

Associated Gene

PNPLA6

Inheritance

This condition is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.

Other Names

Ataxia-hypogonadism-choroidal dystrophy syndrome
BNHS
BNS
Cerebellar ataxia with hypogonadism and choroidal dystrophy syndrome
Chorioretinal dystrophy, spinocerebellar ataxia, and hypogonadotropic hypogonadism
Spinocerebellar ataxia, hypogonadotropic hypogonadism, and chorioretinal dystrophy

Additional Information & Resources

Genetic Testing Information

Genetic Testing Registry: Ataxia-hypogonadism-choroidal dystrophy syndrome

Genetic and Rare Diseases Information Center

Ataxia-hypogonadism-choroidal dystrophy syndrome

Patient Support and Advocacy Resources

National Organization for Rare Disorders (NORD)

Catalog of Genes and Diseases from OMIM

BOUCHER-NEUHAUSER SYNDROME; BNHS

Scientific Articles on PubMed

PubMed

References

Deik A, Johannes B, Rucker JC, Sanchez E, Brodie SE, Deegan E, Landy K, Kajiwara Y, Scelsa S, Saunders-Pullman R, Paisan-Ruiz C. Compound heterozygous PNPLA6 mutations cause Boucher-Neuhauser syndrome with late-onset ataxia. J Neurol. 2014 Dec;261(12):24